“ADVANTAGES OF USING LIPOSOME-ENCAPSULATED ANTIBIOTICS TO FIGHT INFECTIONS CAUSED BY ENTEROBACTERIA”. Journal of Population Therapeutics and Clinical Pharmacology 31, no. 9 (September 7, 2024): 731–740. Accessed September 28, 2024. https://jptcp.com/index.php/jptcp/article/view/7835.